Vestal Point Capital’s Alto Neuroscience ANRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.09M | Buy |
950,000
+35,000
| +4% | +$77K | 0.11% | 62 |
|
|
2025
Q1 | $1.98M | Hold |
915,000
| – | – | 0.14% | 55 |
|
|
2024
Q4 | $3.87M | Buy |
915,000
+265,000
| +41% | +$1.12M | 0.23% | 58 |
|
|
2024
Q3 | $7.44M | Buy |
650,000
+30,000
| +5% | +$343K | 0.56% | 40 |
|
|
2024
Q2 | $6.63M | Buy |
620,000
+370,000
| +148% | +$3.96M | 0.49% | 41 |
|
|
2024
Q1 | $3.84M | Buy |
+250,000
| New | +$3.84M | 0.32% | 48 |
|